Related Experiment Video
Updated: Feb 28, 2026
04:50
The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination
Published on: February 8, 2022
6.7K
Hepatic glycogenosis: a diagnostic challenge.
Diana Horta1, Maria-Rosa Escoda2, Luigi Melcarne3
1Aparato Digestio, Parc Tauli, España.
Revista Espanola De Enfermedades Digestivas
|June 20, 2017
Summary
Hepatic glycogenosis (HG) is a rare liver condition. A recent case highlights its potential misdiagnosis as steatohepatitis, especially in patients with type 1 diabetes.
Area of Science:
- Hepatology
- Endocrinology
- Internal Medicine
Background:
- Hepatic glycogenosis (HG) is a rare metabolic disorder.
- It involves abnormal accumulation of glycogen in liver cells.
- Less than 20 adult cases of HG have been reported.
Observation:
- A young female patient with poorly controlled type 1 diabetes presented with right upper quadrant pain.
- Elevated serum transaminases and gamma-glutamyl transferase (GGT) were noted.
- Other potential causes of liver disease were systematically excluded.
Findings:
- A liver biopsy confirmed the diagnosis of hepatic glycogenosis.
- The patient's symptoms and biochemical profile were consistent with HG.
- This case underscores the diagnostic challenges of HG.
Implications:
- Hepatic glycogenosis can mimic other liver conditions like steatohepatitis.
- Early recognition and diagnosis of HG are crucial for appropriate management.
- Further research into HG pathogenesis and clinical presentation is warranted.
Related Concept Videos
01:20Inborn Errors of Metabolism
961
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
961
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
01:15Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
01:19Overview of Carbohydrate Metabolism
3.9K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.9K
01:27Glucose Transporters
27.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.8K